Microneedle treatment for peach allergy
Part of Immune system & allergy clinical trials.
This study looks at a new way to treat peach allergy using tiny microneedles. It aims to find better tests for diagnosing the allergy and to see if this treatment can help people build tolerance, so they can eat peaches safely.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 14 to 65 years old.
- You must have a peach allergy caused by a specific protein (LTP) — this is confirmed with skin tests or a blood test for Pru p 3.
- You must not be pregnant or breastfeeding.
- You must not have immune system diseases, mental illness, or severe eczema.
- You must not be taking drugs that affect the immune system (immunomodulators) or beta-blockers (heart/blood pressure meds).
- Your lung function (spirometry) must be normal (not less than 70% of expected).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a medication called omalizumab (a common allergy drug) to see if it can help people with severe allergies to plant foods like peach and melon, especially when standard treatments have failed. If you qualify, you may receive the drug and be monitored to see if your food allergies improve.
This study is testing whether a natural fiber called pectin can help people who are allergic to peach (and sometimes peanut) due to a specific protein (LTP). You would eat pectin every day for a while and then have food challenges to see if your allergy gets better.
This trial tests an oral (by mouth) immune treatment for people with confirmed peanut allergy. It aims to see whether your immune system can become less reactive to peanuts over time, while keeping you safe during testing with careful emergency planning.
This trial tests a new medication called RPT904 in people with IgE-mediated food allergies to foods like peanut, milk, egg, cashew, or walnut. The goal is to see if it reduces allergic reactions when you eat a small amount of the food.
This early-phase trial tests a new medication, LCA-0061, in healthy people with high IgE levels (a sign of allergies). Part B specifically includes those with a peanut allergy. The study aims to see how safe the drug is and how the body processes it.
This study tests whether a treatment program can help children and teenagers with peanut allergies develop tolerance to peanuts over time. The goal is to reduce the risk of serious allergic reactions if they accidentally eat peanuts.
Hear when a new Food Allergies trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.